Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide-MMX in Active Ulcerative Colitis
NCT01100112Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Feb 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Feb 2010; status: completed.
02
Drugs
EPI-EE
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01100112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100112.